Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Mozambique

HIV Epidemic

  • 10.5% Estimated HIV prevalence among adults 15–49 Years (2015)
  • 34,000 Estimated AIDS-related deaths among adults 15+ Years (2015)
  • 802,659 Estimated number of adults living with HIV receiving antiretroviral treatment (ART) (2015)

Source: UNAIDS Global Report 2016

TB Epidemic

  • 551/100,000 Estimated TB Incidence (2015)
  • 51% of tested TB patients who were HIV-positive (2015)

Source: WHO Global TB Control Report 2016

 

What We Do

HIV

For over a decade, CDC has supported Mozambique’s Ministry of Health (MoH) in delivering HIV prevention, care, and treatment services, as well as strengthening laboratory, surveillance, and workforce capacity. CDC has supported operational research in all 11 provinces and provides clinical support for the seven provinces that comprise 75% of the country’s total HIV burden. Additionally, CDC supports the delivery of antiretroviral therapy (ART) to nearly 300,000 adults and children in Mozambique, and is helping to introduce viral load and drug resistance testing for patients.

TB

CDC has been providing direct technical assistance to the National TB Program in Mozambique for nearly 10 years, focusing on integration of TB/HIV services, strengthening of surveillance systems, and diagnosis and treatment of drug-resistant TB. Additionally, CDC has been collaborating with US Government partners, and the government of Mozambique to improve the capacity of two regional laboratories. 

Discover more about CDC’s work in Mozambique by viewing our detailed country profile.

More Information

More information about TB in Mozambique is available online at WHO's TB Country Profiles.
More information about CDC’s global health work in Mozambique is available online at CDC in Mozambique.

Top